The objective of the fund is to provide a total return of capital and income in excess of the total return.
Name | % Net Assets |
---|---|
Egdon Resources | 4.2% |
CML Microsystems | 3.4% |
Abcam | 2.6% |
Brady | 2.6% |
City Of London Investment Group | 2.5% |
Staffline Group | 1.9% |
Volex Group | 1.9% |
Richoux Group | 1.9% |
Research Now | 1.8% |
Alliance Pharma | 1.7% |
Key | % Net Assets |
---|---|
Egdon Resources | 4.2% |
CML Microsystems | 3.4% |
Abcam | 2.6% |
Brady | 2.6% |
Other | 87.2% |
Date | 21-Nov-2024 |
---|---|
Bid | 753.27p |
Offer | 753.27p |
Currency | GBP |
Change | -5.01p |
% | -0.66% |
YTD change | 34.45p |
YTD % | 4.79% |
Fund Inception | 04/10/2004 |
---|---|
Fund Manager | Giles Hargreave |
TER | 1.53 (31-Jul-2012) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £500 |
Savings | £100 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.19 |
You are here: research